|
| LETTER TO EDITOR |
|
|
|
| Year : 2009 | Volume
: 46
| Issue : 2 | Page : 173-174 |
| |
Multiple myeloma with paraneoplastic leucocytoclastic vasculitis
P Jain, P Kumar, PM Parikh
Department of Medical Oncology, Tata Memorial Hospital, Dr. E. Borges Road, Parel, Mumbai-400 012, India
Correspondence Address:
P Jain
Department of Medical Oncology, Tata Memorial Hospital, Dr. E. Borges Road, Parel, Mumbai-400 012
India
 Source of Support: None, Conflict of Interest: None  | Check |
DOI: 10.4103/0019-509X.49159
How to cite this article:
Jain P, Kumar P, Parikh P M. Multiple myeloma with paraneoplastic leucocytoclastic vasculitis. Indian J Cancer 2009;46:173-4 |
Sir
53 year old male, presented to us because of gradual onset of progressively developing body aches, fatigue and multiple ulceronecrotic lesions on both lower limbs on the dorsum of foot and calf area since six to seven months. He had non specific arthralgias from the past one month. Patient had biopsy proven leucocytoclastic vasculitis. He has been evaluated in detail for the skin lesions by various dermatologists. Patient had leucocytoclastic vasculitis and was on topical steroids and anti-fungal creams. On examination, there were different sized ulceronecrotic patchy lesions with necrosis, without any pus discharge, present in the legs and feet [Figure 1]. A Complete Blood count (CBC), renal and liver functions tests, coagulation tests, serum electrolytes, calcium, phosphorus and chest X-ray were normal. Anti nuclear antibodies (ANA), anti neutrophil cytoplasmic antibodies (ANCA) and anti double stranded (ds) DNA antibodies, cryoglobulins, HIV and hepatitis B and C panels were negative. Compliment levels were normal. ESR was 91 mm in first hour and total serum protein levels were 8.5 gm% (normal 6.4-8.3 gm %). Serum immunofixation and electrophoresis showed an "M" band in the gamma globulin zone, the concentration of which was 3 gm/dL with serum Immunoglobulin G (IgG) levels elevated at 3600 mg/dL. IgA and IgM were at normal levels. An immunoelectrophoretic study confirmed the monoclonal IgG - kappa chain peak. Urinary bence Jones were negative. Bone marrow biopsy showed a plasma cell infiltrate of 35%. Serum beta 2 microglobulins were 1.52 mg/L (Normal value was 0.83 - 1.15 mg/L). A skeletal survey revealed osteolytic lesions in the first rib, right femur intertrochantric region. Skin biopsy of the lesions showed thrombosis involving a large number of upper dermal, small-sized arteries, as well as leucocytoclastic vasculitis, with fibrinoid deposits within the capillary walls in the upper and lower dermis [Figure 2]. Based on all above data the patient was diagnosed as multiple myeloma stage III a. The patient was treated with six cycles of vincristine adriamycin and dexamethasone (VAD) with monthly pulse of zolendronate. There was remarkable improvement in the ulceronecrotic lesions and patient symptoms. The "M" band concentration fell to 100 mg/dL. The patient is in regular follow up and is on monthly zolendronate.
Paraneoplastic vasculitis is a known entity; cutaneous vasculitis is the most commonly observed paraneoplastic vasculitis. It constitutes 30 - 40% of all paraneoplastic vasculitis. [1] Most of the cases of cutaneous paraneoplastic vasculitis are associated with hematological malignancies (90%). [2]
The association of myeloma with cutaneous paraneoplastic vasculitis is very rare. Only about 11 cases of paraneoplastic cutaneous vasculitis associated with myeloma were reported so far. [3],[4] Myeloma associated cutaneous vasculitis is mostly associated with IgA type but our case had Ig G type of myeloma. [3] Only two cases with predominantly ulceronecrotic lesions have been reported. Systemic involvement was present only in two cases. [3]
In our case the, vasculitis improved once treatment was started in our case but skin grafting was needed as the ulcers were large and deep. [2,5] This patient's skin biopsy showed typical features of vasculitis. [1]
Immunofluorescence studies show immunoglobulin or compliment deposits in vessel walls. Vasculitis usually responds to steroids or to treatment of primary cancer and its prognosis depends on the underlined malignancy. [1]
| » References | |  |
| 1. | Kurzrock R, Cohen PR. Vasculitis and cancer. Clin Dermatol 1993;11:175-87.  [PUBMED] [FULLTEXT] |
| 2. | Hayem G, Gomez MJ, Grossin M, Meyer O, Kahn MF. Systemic vasculitis and epithelioma. Rev Rhum Engl Ed 1997;64:816-24. [PUBMED] |
| 3. | Sanchez NB, Canedo IF, Garcia-Patos PE, Perez PU, Benito AV, Pascual AM. Paraneoplastic vasculitis associated with multiple myeloma. J Eur Acad Dermatol Venereol 2004;18:731-5. |
| 4. | Bayer -Garner IB, Smoller BR. Leukocytoclastic vasculitis in multiple myeloma. Clin Exp Dermatol 2003;28:521-4. |
| 5. | Kurzrock R, Cohen PR, Markowitz A. Clinical manifestations of vasculitis in patients with solid tumors. Arch Intern Med 1994;154:334-40. [PUBMED] |
[Figure 1], [Figure 2]
| This article has been cited by | | 1 |
Autoimmune Disorders and Multiple Myeloma- Two Illustrative Case Reports and a Literature Review |
|
| Ana María Ávila,Sergio Giralt | | Revista Colombiana de Cancerología. 2018; 22(2): 76 | | [Pubmed] | [DOI] | | | 2 |
Autoimmune manifestations in patients with multiple myeloma and monoclonal gammopathy of undetermined significance |
|
| Alexei Shimanovsky,Argote J. Alvarez,Shruti Murali,Constantin A. Dasanu | | BBA Clinical. 2016; 6: 12 | | [Pubmed] | [DOI] | | | 3 |
Manifestations dermatologiques des gammapathies monoclonales : apport de l’histopathologie cutanée |
|
| Caroline Lacoste,Saskia Ingen-Housz-Oro,Nicolas Ortonne | | Annales de Pathologie. 2015; 35(4): 281 | | [Pubmed] | [DOI] | | | 4 |
The Spectrum of Paraneoplastic Cutaneous Vasculitis in a Defined Population |
|
| Javier Loricera,Vanesa Calvo-Río,Francisco Ortiz-Sanjuán,Marcos A. González-López,Hector Fernández-Llaca,Javier Rueda-Gotor,Maria C. Gonzalez-Vela,Lino Alvarez,Cristina Mata,Domingo González-Lamuño,Victor M. Martínez-Taboada,Miguel A. González-Gay,Ricardo Blanco | | Medicine. 2013; 92(6): 331 | | [Pubmed] | [DOI] | | | 5 |
Vascularite leucocytoclasique paranéoplasique révélant un myélome à IgA |
|
| Chahinaz Abouzaid,Mouna Zahlane,Laila Benjilali,Badiaa Belaabidia,Lamiaa Essaadouni | | La Presse Médicale. 2013; 42(4): 482 | | [Pubmed] | [DOI] | | | 6 |
Paraneoplastic cutaneous leukocytoclastic vasculitis disclosing IgA multiple myeloma [Vascularite leucocytoclasique paranéoplasique révélant un myélome à IgA] |
|
| Abouzaid, C. and Zahlane, M. and Benjilali, L. and Belaabidia, B. and Essaadouni, L. | | Presse Medicale. 2013; 42(4 PART1): 482-484 | | [Pubmed] | | | 7 |
Myelodysplasia and malignancy-associated vasculitis |
|
| Agha, A. and Bateman, H. and Sterrett, A. and Valeriano-Marcet, J. | | Current Rheumatology Reports. 2012; 14(6): 526-531 | | [Pubmed] | | | 8 |
Cutaneous vasculitis associated with recurrence of CLL [Vascularite cutanée associée à une rechute de LLC] |
|
| Bernard, S. and Quinchon, J.-F. and Modiano, P. | | Nouvelles Dermatologiques. 2012; 31(1): 17-19 | | [Pubmed] | | | 9 |
Myelodysplasia and Malignancy-Associated Vasculitis |
|
| Amir Agha,Helen Bateman,Ashley Sterrett,Joanne Valeriano-Marcet | | Current Rheumatology Reports. 2012; 14(6): 526 | | [Pubmed] | [DOI] | | | 10 |
Paraneoplastic vasculitis and paraneoplastic vascular syndromes |
|
| Buggiani, G. and Krysenka, A. and Grazzini, M. and Vašků, V. and Hercogová, J. and Lotti, T. | | Dermatologic Therapy. 2010; 23(6): 597-605 | | [Pubmed] | | | 11 |
Paraneoplastic syndromes: An approach to diagnosis and treatment |
|
| Pelosof, L.C., Gerber, D.E. | | Mayo Clinic Proceedings. 2010; 85(9): 838-854 | | [Pubmed] | | | 12 |
Paraneoplastic vasculitis and paraneoplastic vascular syndromes : Vascular syndromes |
|
| Gionata Buggiani, Alena Krysenka, Marta Grazzini, Vladimír Vašků, Jana Hercogová, Torello Lotti | | Dermatologic Therapy. 2010; 23(6): 597 | | [VIEW] | [DOI] | | | 13 |
Paraneoplastic Syndromes: An Approach to Diagnosis and Treatment |
|
| Lorraine C. Pelosof, David E. Gerber | | Mayo Clinic Proceedings. 2010; 85(9): 838 | | [VIEW] | [DOI] | |
|
|
|
|
|
|
|
|
